BRGX · Bioregenx, Inc. · Holdings
$0.00
+0.00 (+0.00%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern. As reflected in the accompanying financial statements, for the three months ended March 31, 2026, the Company incurred a net loss of $(26,415), generated cash from operations of $26,629 and had a stockholder's deficit of $4,533,316 as of that date. At March 31, 2026, the Company had cash on hand in the amount of $45,806. In addition, notes payable of $522,500 are in default. As a result, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Market Cap
$194,315
Shares
971.58M
Volume · Oct 23
17.6K
Avg daily vol (3M)
119.2K
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Use institutional holdings through the 13F API or MCP →
See every holder of BRGX: 13F, 13D and 13G, insiders and funds →
Recent SEC filings are still being reconciled. Holder totals and changes may be incomplete until processing catches up.
No Holdings Data
No institutional holdings data is available for this listed security yet.